(Q44828678)
Statements
Post-treatment, but not pre-treatment, with the selective cyclooxygenase-2 inhibitor celecoxib markedly enhances functional recovery from kainic acid-induced neurodegeneration (English)
Gobbo OL
1 reference
scientific article published in January 2004